Strand Life Sciences Develops Prenatal Genomic Diagnostics Portfolio
Bengaluru: Strand Life Sciences, a subsidiary of Reliance Industries Ltd., and a leading global provider of genomic and bioinformatic solutions, proudly announces its prenatal screening and diagnostics portfolio with two breakthrough technologies: CNSeq (for identification of aneuploidies and copy number variations) and MaatriSeq (Non-Invasive Prenatal Screening). These innovations are tailored to the specific needs of … Read more